Brain tumor patients may skip routine steroids during surgery
NCT ID NCT07044557
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether it is safe to avoid giving the steroid dexamethasone before, during, and for three weeks after brain metastasis surgery. The goal is to see if patients can avoid the side effects of steroids without needing extra rescue doses. The trial will enroll 35 adults with newly found brain tumors and a suspected or confirmed cancer elsewhere in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
withholding dexamethasone (steroid)
What this could lead to
If successful, this could show that many patients with brain metastases can safely avoid routine steroids around surgery, reducing side effects.
What could go wrong
This is a very small, early-phase study (35 people) with no control group. It only tests whether steroids can be withheld, not whether this improves long-term outcomes. Some patients may still need rescue steroids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Louisville Hospital
RECRUITINGLouisville, Kentucky, 40202, United States
Contact
Contact Phone: •••-•••-••••